PAH patients show reduced expression of the co-stimulatory factor CD86 on monocyte-derived dendritic cells (MoDCs), leading to impaired function in the PAH-initiated immune or immune tolerance state (97). Here, CD86 is linked to pulmonary arterial hypertension.